The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome.

Autor: de Groot, P. G.¹ Ph.G.deGroot@umcutrecht.nl, Derksen, R. H. W. M.², Urbanus, R. T.¹

Publikováno v: Lupus. Apr2010, Vol. 19 Issue 4, p389-393. 5p.

New developments in lupus-associated antiphospholipid syndrome.

Autor: Lockshin, M. D.¹, Derksen, R. H. W. M.² r.h.w.m.derksen@umcutrecht.nl

Publikováno v: Lupus. 2008, Vol. 17 Issue 5, p443-446. 4p.

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Autor: Cervera, R. Serrano, R. Pons-Estel, G. J. Ceberio-Hualde, L. and Shoenfeld, Y. de Ramon, E. Buonaiuto, V. Jacobsen, S. and Zeher, M. M. Tarr, T. Tincani, A. Taglietti, M. and Theodossiades, G. Nomikou, E. Galeazzi, M. Bellisai, F. and Meroni, P. L. Derksen, R. H. W. M. de Groot, P. G. D. and Baleva, M. Mosca, M. Bombardieri, S. Houssiau, F. Gris, J-C Quere, I. Hachulla, E. Vasconcelos, C. and Fernandez-Nebro, A. Haro, M. Amoura, Z. Miyara, M. and Tektonidou, M. Espinosa, G. Bertolaccini, M. L. Khamashta, M. A. Euro-Phospholipid Project Grp

Objectives To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later. Methods In 1999, w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::d3ceb41307e7345747af6b6c27d88348
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3166148

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis

Autor: Suzanne Arends, Berden, J. H. M., Grootscholten, C., Derksen, R. H. W. M., Berger, S. P., Sévaux, R. G. L., Voskuyl, A. E., Bijl, M.

Publikováno v: The Netherlands Journal of Medicine, 72(9), 481-490. van Zuiden Communications BV.
Scopus-Elsevier
Netherlands Journal of Medicine, 72(9), 481-490. Van Zuiden Communications BV
Arends, S, Berden, J H M, Grootscholten, C, Derksen, R H W M, Berger, S P, de Sevaux, R G L, Voskuyl, A E & Bijl, M 2014, ' Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis ', Netherlands Journal of Medicine, vol. 72, no. 9, pp. 481-490 .

Background: For decades, high-dose intravenous cyclophosphamide (ivCY) given for 24-30 months was regarded as the standard therapy for proliferative lupus nephritis, despite serious side effects. Our aim was to evaluate the effect of induction therap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::56ee87d5198299e4b0140f6cfb51000b
https://research.rug.nl/en/publications/1223be1c-7e0c-4e2d-a120-57d00c6973af